Benzinga | Feb 25, 2021 08:04AM EST

Pacira BioSciences Q4 EPS $0.32 Down From $0.56 YoY, Adj. EBITDA $42.9M, Sales $131.00M Miss $131.57M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.32 per share. This is a 42.86 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $131.00 million which missed the analyst consensus estimate of $131.57 million by 0.43 percent. This is a 7.01 percent increase over sales of $122.42 million the same period last year.